---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-059518"
form_type: "8-K"
ticker: "ICU"
cik: "0001831868"
company_name: "SeaStar Medical Holding Corp"
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T01:11:18.289951+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SeaStar Medical Q1 net loss $12.7M, cash rises to $5M; Quelimmune launch imminent

## Summary
- Net loss $12.7M ($0.19 per share) vs $7.1M ($0.54) in Q1 2023; no revenue recorded.
- Cash and cash equivalents $5.0M as of March 31, 2024, up from $176K at Dec 31, 2023.
- Quelimmune Pediatric received FDA approval in Feb 2024; initial sales expected in coming weeks at five children's hospitals.
- NEUTRALIZE-AKI adult trial enrolled 31 subjects at eight sites; regulatory approval expected H2 2025.
- January 2024 $9M at-the-market offering and appointment of David A. Green as CFO.

## SEC filing metadata
- accession: 0000950170-24-059518
- form_type: 8-K
- ticker: ICU
- cik: 0001831868
- company_name: SeaStar Medical Holding Corp
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831868/000095017024059518/0000950170-24-059518-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831868/000095017024059518/icu-20240514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-059518
- JSON: https://secwatch.observer/filing/0000950170-24-059518.json
- Plain text: https://secwatch.observer/filing/0000950170-24-059518.txt

## Key facts
- Earnings Releases
  SeaStar Medical Holding Corp reported financial results for the three months ended March 31, 2024.
  - Period: the three months ended March 31, 2024
  - Result: reported results
  source text: On May 14, 2024, SeaStar Medical Holding Corporation (the “Company”) issued a press release announcing its financial condition and results of operations for the fiscal quarter-ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831868/000095017024059518/0000950170-24-059518-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.